• About
  • Subscribe
  • Advertise
  • Contact
Saturday, May 24, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

RANZCO CEO Dr David Andrews announces departure

by Myles Hume
December 14, 2021
in Local, News
Reading Time: 4 mins read
A A
Dr David Andrews - RANZCO CEO

The search for Dr David Andrews' replacement has begun, as he plans to step down early in 2022.

Share on FacebookShare on Twitter

RANZCO CEO Dr David Andrews has informed the college board he is standing down from the role he has served in since 2013. He is leaving to become CEO of the Australian Veterinary Association.

RANZCO president Professor Nitin Verma announced his departure in a memo, advising that Andrews would be leaving the role in early 2022 and hoped he would be present for a farewell at the upcoming scientific congress in February in Brisbane.

Prior to his college appointment, Andrews previously served as chief operating officer of the Woolcock Institute of Medical Research and held senior roles within the biotech sector.

In an interview with Insight, Andrews reflected on the successes, mistakes and key learnings during his nine-year tenure.

Noting that much of the achievements required a team effort, he was proud of governance changes at RANZCO under his tutelage, including updating the constitution, obtaining full health charity status, and improving the process for identifying new committee members allowing for greater fellow involvement.

“While we had a rough few years with the Australian Medical Council and Medical Council of New Zealand accreditation, we are now in a position to have met nearly all our conditions and recommendations, and on track to complete them next year,” he said.

“The congresses have certainly lifted in quality during my tenure, helped largely by our PCO and the dedicated staff, but also a greatly improved direct relationship with industry. I am also proud of the improvement in quality of our own magazine Eye2Eye and the success of CEO Journal, for which I can take little credit other than supporting the managing editors and fellows involved.”

Andrews was also pleased to with efforts to attract Indigenous trainees in Australia and New Zealand. He also believes the college’s relationships across the sector have improved, not just with optometry but patient advocacy groups such as Macular Disease Foundation Australia and their equivalent in New Zealand, Glaucoma Australia, Vision 2020 Australia and other smaller groups.

“I also have an excellent working relationship with the management of the Australian Society for Ophthalmology and Kerry Gallagher has provided much sage advice over many years,” he said.

“I was particularly pleased when we were awarded hosting rights to the World Ophthalmology Congress, which would have been in a few months in Melbourne but of course COVID killed that. From a more operational perspective I leave RANZCO on a very solid financial footing with a strong balance sheet, the staff we have are excellent and in many cases are highly specialised in their fields. This has taken years to build and part of the reason for moving on now is that I feel I am leaving the college in excellent hands and overall great health.”

Mistakes, trust, patience and perseverance

In terms of what he has learned about himself professionally, Andrews highlighted patience and perseverance. It’s not an easy role leading a medical college and, although he wasn’t expecting that, he noted the pace of change in some areas has been slow.

“I have learnt to look at things in different ways and look for the other story before making important decisions,” he said.

“I’m sure I didn’t always do that, and sometimes the easy option is not always the best, so I have made mistakes along the way. But that’s part of any job. I have also learnt to trust my team more. Some of the staff have been here through my whole tenure and had multiple roles. I can trust them to do a great job without having to check every detail.”

As CEO of the Australian Veterinary Association, Andrews expects similar governance structures and issues to RANZCO, as well as advocacy aims and challenges.

“[It’s] just at a different life-cycle which provides some good opportunities for me. I think it’s a good fit.”

Speaking of his CEO, Verma said Andrews had led the college into a very strong position across the college’s core areas of ophthalmic education, advocacy and membership services.

“David has nurtured an environment of professionalism and specialisation within the College office, bringing us experts with the specific skills and attributes we need for the future. He will be leaving us a much stronger and resilient organisation than when he started.”

RANZCO has subsequently began seeking a recruitment firm to appoint a replacement. Andrews will remain in his role as the college initiates this process.

More reading

RANZCO ‘ahead of the curve’ with major CPD changes on horizon

Regionally based private ophthalmologists in NSW under increasing pressure – RANZCO

RANZCO’s top ophthalmology trainers of 2021 revealed

Tags: CEODr David AndrewsophthalmologyProfessor Nitin VermaRANZCO

Related Posts

Rodenstock’s new B.I.G. Exact Sensitive lenses are now available in Australia. Image: Rodenstock.

Try before you buy – a personal, exacting trial for Rodenstock lenses

by Rob Mitchell
May 23, 2025

Rodenstock has made some significant statements about its new B.I.G Exact Sensitive lenses. The director of a Melbourne optometry practice...

The Eyerising Myopia Management Device was approved in Australia in 2023. Image: Eyerising International.

Eyerising International addresses ‘limitations’ of red light study suggesting reduced cone density  

by Staff Writer
May 23, 2025

The inventor of the Eyerising International repeated low-level red light (RLRL) therapy for myopia, Professor Mingguang He, has outlined “notable...

CR Labs' ECO7 lens follows the success of its ECO6 product. Image: CR Labs.

CR Labs launches new sustainable lens in thinner format

by Staff Writer
May 22, 2025

CR Labs has launched ECO7, its latest innovation in sustainable lens technology. The company says the new lens builds on...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited